Table 2.
Symptom Prevalence, Severity and Interference with Daily Activities among Emerging Adults with Inflammatory Bowel Disease (N=61)
| Prevalence N (%) | Severity M (SD) | Interference M (SD) | PROMIS T-score M (SD) | |
|---|---|---|---|---|
| IBD Symptom Inventory | ||||
| Fatigue | 44 (72.1%) | 4.1 (2.9) | 3.3 (2.6) | |
| Abdominal cramps | 42 (68.9%) | 3.2 (3.0) | 2.1 (2.5) | |
| Abdominal pain | 39 (63.9%) | 2.8 (2.6) | 1.5 (1.9) | |
| Diarrhea | 38 (62.3%) | 2.8 (2.7) | 2.1 (2.6) | |
| Passing gas | 37 (60.7%) | 3.2 (3.0) | 1.3 (2.0) | |
| Bloating | 31 (50.8%) | 2.3 (2.7) | 0.9 (1.7) | |
| Abdominal tenderness | 30 (49.2%) | 2.3 (2.7) | 1.1 (1.9) | |
| Nausea or vomiting | 29 (47.5%) | 2.0 (2.6) | 1.2 (1.8) | |
| Reduced appetite | 20 (32.8%) | 1.3 (2.1) | 0.5 (1.2) | |
| Constipation | 18 (29.5%) | 1.4 (2.4) | 0.8 (1.7) | |
| Blood in stool | 15 (24.6%) | 1.1 (2.4) | 0.4 (1.5) | |
| Increased appetite | 6 (9.8%) | 0.5 (1.6) | 0.3 (1.5) | |
| Weight loss | 5 (8.2%) | 0.2 (0.8) | 0.01 (0.1) | |
| Weight gain | 3 (4.9%) | 0.2 (1.2) | 0.1 (1.2) | |
| Fever | 3 (4.9%) | 0.1 (0.7) | 0.1 (0.5) | |
| PROMIS Symptom Measures | ||||
| Anxietya | 58.1 (9.4) | |||
| Depressiona | 55.5 (10.1) | |||
| Fatiguea | 58.9 (10.0) | |||
| Sleep disturbancea | 53.0 (4.6) | |||
| Pain interferencea | 50.7 (8.1) | |||
| Pain intensity (range 0-10) | 2.4 (1.8) | |||
| PROMIS Functioning Measures | ||||
| Physical functioningb | 39.0 (7.2) | |||
| Satisfaction with social roleb | 27.7 (5.0) |
a
A higher T-score indicates increased symptom severity
b
A higher T-score indicates improved functioning
N = Number; % = Percentage; M = Mean; SD = Standard Deviation; IBD = Inflammatory Bowel Disease; PROMIS = Patient-Reported Outcomes Measurement Information System